Smith, Moore & Co’s Zoetis ZTS Stock Holding History

Smith, Moore & Co’s Portfolio ZTS Stock Details ZTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-2,406	Closed	-$201K	–	350
2018 Q1	$201K	Buy	+2,406	New	+$190K	0.05%	298

Other funds holding ZTS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Smith, Moore & Co's ZTS Position: Q2 2018 in Review

Smith, Moore & Co sold out of Zoetis (ZTS) in Q2 2018, closing a stake of 2,406 shares — an estimated $201K sold.

Smith, Moore & Co first reported a position in ZTS in Q1 2018 and held it in 1 quarter. The position peaked at $201K in Q1 2018. 951 funds tracked by Wall St. Rank hold ZTS as of Q2 2018.

Smith, Moore & Co reported no remaining Zoetis position as of Q2 2018 after selling out during the quarter.
Smith, Moore & Co sold 2,406 Zoetis shares in Q2 2018, an estimated $201K.
Smith, Moore & Co first reported a position in Zoetis in Q1 2018 and held it in 1 quarter.
Smith, Moore & Co's Zoetis position peaked at $201K in Q1 2018.
951 funds tracked by Wall St. Rank held Zoetis as of Q2 2018.

Based on Smith, Moore & Co's 13F filing for Q2 2018, filed 14 Aug 2018.